1![CLIENT PROGRAMS MEET OUR NEW WORKING WHEELS TEAM At the end of last year I was diagnosed with limb-girdle muscular dystrophy. Through Working Wheels (WW) CLIENT PROGRAMS MEET OUR NEW WORKING WHEELS TEAM At the end of last year I was diagnosed with limb-girdle muscular dystrophy. Through Working Wheels (WW)](https://www.pdfsearch.io/img/f01c346f9fdf2ede9e5aa13dc9cffa6a.jpg) | Add to Reading ListSource URL: mdnsw.org.auLanguage: English - Date: 2015-06-28 21:29:23
|
---|
2![ZOMBIE FACT #1 CIRCLES Muscular dystrophy, hemiplegia, even complete loss of limbs are common in zombies. The sum of these things means that zombies often end up shambling around in circles. This puzzle requires site sp ZOMBIE FACT #1 CIRCLES Muscular dystrophy, hemiplegia, even complete loss of limbs are common in zombies. The sum of these things means that zombies often end up shambling around in circles. This puzzle requires site sp](https://www.pdfsearch.io/img/79b3a5b39f0cbd3249b367bf0fe3b1eb.jpg) | Add to Reading ListSource URL: www.baphl.org- Date: 2013-10-26 21:45:02
|
---|
3![Microsoft Word - ASX 17_ 2 October_ ATL1102 for Multiple Sclerosis and Duchenne Muscular Dystrophy Update summary_Final Microsoft Word - ASX 17_ 2 October_ ATL1102 for Multiple Sclerosis and Duchenne Muscular Dystrophy Update summary_Final](https://www.pdfsearch.io/img/d6bb531bdc23805f78de241adcdb2adf.jpg) | Add to Reading ListSource URL: www.antisense.com.auLanguage: English - Date: 2017-10-02 22:11:30
|
---|
4![19 DecemberATL1102 for Multiple Sclerosis and Duchenne Muscular Dystrophy Update Antisense Therapeutics Limited (“ANP” or “the Company”) provides the following update on the progress of its Multiple Sclero 19 DecemberATL1102 for Multiple Sclerosis and Duchenne Muscular Dystrophy Update Antisense Therapeutics Limited (“ANP” or “the Company”) provides the following update on the progress of its Multiple Sclero](https://www.pdfsearch.io/img/c2acb9fdfd316c350f8847b15b2b9d71.jpg) | Add to Reading ListSource URL: www.antisense.com.auLanguage: English - Date: 2018-02-11 19:58:19
|
---|
5![](/pdf-icon.png) | Add to Reading ListSource URL: www.curesma.org- Date: 2015-05-15 13:09:02
|
---|
6![Keeping Hope Alive By Al Freedman, Ph.D. Reprinted with permission by Quest, the national magazine of the Muscular Dystrophy Association, Volume 10, Number 1, FebruaryI’ll always remember the day our first child Keeping Hope Alive By Al Freedman, Ph.D. Reprinted with permission by Quest, the national magazine of the Muscular Dystrophy Association, Volume 10, Number 1, FebruaryI’ll always remember the day our first child](https://www.pdfsearch.io/img/089afb16443de343fd70efbd88fbba77.jpg) | Add to Reading ListSource URL: www.curesma.org- Date: 2015-07-21 11:37:45
|
---|
7![FINAL Catabasis Pharmaceuticals Announces the Initiation of an Open-Label Extension for the MoveDMD® Trial Studying Edasalonexent (CATin Duchenne Muscular Dystrophy CAMBRIDGE, MA, July 7, 2016 – Catabasis Phar FINAL Catabasis Pharmaceuticals Announces the Initiation of an Open-Label Extension for the MoveDMD® Trial Studying Edasalonexent (CATin Duchenne Muscular Dystrophy CAMBRIDGE, MA, July 7, 2016 – Catabasis Phar](https://www.pdfsearch.io/img/e12e00929f06e4321d4c4fec49484ad5.jpg) | Add to Reading ListSource URL: www.catabasis.com- Date: 2016-07-07 08:01:15
|
---|
8![Screening S. aureus CRISPR-Cas9 Paired Guide RNAs for Efficient Targeted Deletion in Duchenne Muscular Dystrophy Josh Tycko1, Nick Huston1, Jacqueline Robinson-Hamm2, Chris Wilson1, Charles A. Gersbach2, Patrick D. Hsu1, Screening S. aureus CRISPR-Cas9 Paired Guide RNAs for Efficient Targeted Deletion in Duchenne Muscular Dystrophy Josh Tycko1, Nick Huston1, Jacqueline Robinson-Hamm2, Chris Wilson1, Charles A. Gersbach2, Patrick D. Hsu1,](https://www.pdfsearch.io/img/1fc6a0d787ff89a4af2a40d645ec6e07.jpg) | Add to Reading ListSource URL: www.editasmedicine.com- Date: 2016-08-22 09:22:03
|
---|
9![](/pdf-icon.png) | Add to Reading ListSource URL: www.actionduchenne.org- Date: 2015-11-16 06:32:46
|
---|
10![JettRide Application Join the JettRide. Be a JettRider to raise funds and awareness for the fight against Duchenne muscular dystrophy. JettRiders must submit a $100 rider fee with this completed and signed application fo JettRide Application Join the JettRide. Be a JettRider to raise funds and awareness for the fight against Duchenne muscular dystrophy. JettRiders must submit a $100 rider fee with this completed and signed application fo](https://www.pdfsearch.io/img/e76c9e5a647b362a4cd297689a84f171.jpg) | Add to Reading ListSource URL: jettride.jettfoundation.org- Date: 2015-05-29 11:27:34
|
---|